Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hardik Bhagat"'
Autor:
Anton I. Skaro, Jason J. Schwartz, Samantha Montag, Raymond Kang, Kofi Atiemo, Bing Ho, Edward Lee, Lihui Zhao, Amna Daud, Daniela P. Ladner, Hardik Bhagat
Publikováno v:
Advances in Therapy
Introduction Real-world data with extended-release tacrolimus (ER-T) are lacking in the USA. This study examined clinical outcomes and healthcare resource utilization in kidney transplant patients receiving ER-T in clinical practice. Methods This was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51254b37c17744e44b225c977ea72b64
https://pubmed.ncbi.nlm.nih.gov/30941724
https://pubmed.ncbi.nlm.nih.gov/30941724
Autor:
Hardik Bhagat, James Spalding, Hongbo Yang, Yanqing Xu, Mo Zhou, Ela Fadli, Jing Zhao, Yan Song
Publikováno v:
Open Forum Infectious Diseases
Background Invasive mold infections (IMIs) are an increasing cause of morbidity and mortality worldwide.1 Pharmacological differences among the currently available mold-active triazoles make treatment selection complex.1 To the best of our knowledge,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7adab2a3e77f79bf28fe94d8695760c
http://europepmc.org/articles/PMC6809523
http://europepmc.org/articles/PMC6809523
Autor:
Hardik Bhagat, Reem Nubani, Kathleen L. Matthews, Philip T. Thrush, Elfriede Pahl, John M. Costello, Jeffrey G. Gossett, Carl L. Backer
Publikováno v:
Pediatric transplantation. 18(1)
UNLABELLED rATG is used for HTx induction but is costly and associated with infection and PTLD. HYPOTHESIS Tailoring rATG induction with CD3 monitoring results in less infection, reduced costs, and similar rejection. Retrospective review of HTx recip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e88c8bafa419d0dfeae2f3be774061
https://pubmed.ncbi.nlm.nih.gov/24283506
https://pubmed.ncbi.nlm.nih.gov/24283506